Suchergebnisse - (Subject:"lopinavir")

PubPharm (88)

1

Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors : blockage of its enzymatic activity and interference with fungal growth and macrophage interaction

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2020

von Granato, M. | Sousa, I. | Rosa, T. | +6

2

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Feng, H. | Caro, L. | Fandozzi, C. | +21

3

Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain

enthalten in: Journal of medical virology | 2016

von Pernas, B. | Grandal, M. | Tabernilla, A. | +7

4

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial

enthalten in: PloS one | 2016

von Cooper, D. | Cordery, D. | Zajdenverg, R. | +87

5

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy : a cross-sectional study

enthalten in: BMC infectious diseases | 2014

von Estébanez, M. | Stella-Ascariz, N. | Mingorance, J. | +6

6

Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting : same results as in clinical trials? The PIMOCS Study Group

enthalten in: The Journal of antimicrobial chemotherapy | 2014

von Curran, A. | Monteiro, P. | Domingo, P. | +26

7

Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age

enthalten in: Journal of medical economics | 2014

von Möller, J. | Desai, K. | Simpson, K. | +4

8

Comparative analysis of ER stress response into HIV protease inhibitors : lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway

enthalten in: Free radical biology & medicine | 2013

von Taura, M. | Kariya, R. | Kudo, E. | +7

9

Time to HIV-1 RNA suppression below 5 copies/ml during first-line protease inhibitor-based antiretroviral treatment - any impact of residual viremia on treatment success?

enthalten in: AIDS reviews | 2013

von Ripamonti, D. | Hill, A. | Lauthouwers, E. | +2

10

Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain

enthalten in: Enfermedades infecciosas y microbiologia clinica | 2013

von Smets, E. | Brogan, A. | Hill, A. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]